Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May 25;12(11):1029-1031.
doi: 10.18632/oncotarget.27927.

Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response

Mujib Ullah, Nicole Pek Min Qian, Gustavo Yannarelli
Editorial

Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response

Mujib Ullah et al. Oncotarget. .
No abstract available

Keywords: artificial intelligence; cancer; drug delivery; exosomes; extracellular vesicles.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1. Schematic illustration showing the application of exosome technology in major clinical uses and in different scientific investigation.
See this image and copyright information in PMC

References

    1. Donoso-Quezada J, et al. Crit Rev Biotechnol. 2020; 40:804–20. 10.1080/07388551.2020.1785385. - DOI - PubMed
    1. Zhang Y, et al. Int J Nanomedicine. 2020; 15:6917–34. 10.2147/IJN.S264498. - DOI - PMC - PubMed
    1. Liga A, et al. Lab Chip. 2015; 15:2388–94. 10.1039/c5lc00240k. - DOI - PubMed
    1. Ullah M, et al. Artif Intell Cancer. 2020; 1:39–44. 10.35713/aic.v1.i2.39. - DOI
    1. Ullah M, et al. Stem Cell Res Ther. 2019; 10:347. 10.1186/s13287-019-1468-6. - DOI - PMC - PubMed

Publication types

LinkOut - more resources